Who owns Viking Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of VKTX from SEC Form 13F filings across 438 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 438 institutions disclosed 75.8M shares of Viking Therapeutics, Inc. worth $2.96B — about 65.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
438
13F holders
$2.96B
value, 2026 filers
65.2%
of shares outstanding (75.8M sh)
84
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of VKTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 6.3M | $247.2M | 0.0% | 5.4% | +5.2% |
| 2 | BlackRock, Inc. | 6.2M | $241.5M | 0.0% | 5.3% | -10.0% |
| 3 | STATE STREET CORP | 5.6M | $218.7M | 0.0% | 4.8% | +27.5% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $197.1M | 0.0% | 4.3% | +0.8% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.5M | $174.9M | 0.0% | 3.9% | +0.4% |
| 6 | TWO SIGMA INVESTMENTS, LP | 3.9M | $153.6M | 0.1% | 3.4% | -11.2% |
| 7 | MORGAN STANLEY | 3.5M | $136.0M | 0.0% | 3% | +15.7% |
| 8 | AMERIPRISE FINANCIAL INC | 2.2M | $84.1M | 0.0% | 1.9% | +28.4% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $81.9M | 0.0% | 1.8% | +0.8% |
| 10 | AMERICAN CENTURY COMPANIES INC | 1.8M | $70.8M | 0.0% | 1.6% | -12.6% |
| 11 | D. E. Shaw & Co., Inc. | 1.6M | $62.6M | 0.0% | 1.4% | -4.2% |
| 12 | BNP PARIBAS FINANCIAL MARKETS | 981,700 | $38.3M | 0.0% | 0.8% | +81.6% |
| 13 | CITADEL ADVISORS LLC | 951,515 | $37.1M | 0.0% | 0.8% | -24.6% |
| 14 | GOLDMAN SACHS GROUP INC | 942,841 | $36.8M | 0.0% | 0.8% | -1.8% |
| 15 | UBS Group AG | 936,055 | $36.5M | 0.0% | 0.8% | -30.5% |
| 16 | JPMORGAN CHASE & CO | 915,185 | $36.4M | 0.0% | 0.8% | +88.4% |
| 17 | JANE STREET GROUP, LLC | 899,558 | $35.1M | 0.0% | 0.8% | +20.1% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 816,367 | $31.8M | 0.0% | 0.7% | +15.7% |
| 19 | RAYMOND JAMES FINANCIAL INC | 794,660 | $31.0M | 0.0% | 0.7% | -61.7% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 732,047 | $28.6M | 0.0% | 0.6% | +3.0% |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 730,690 | $28.5M | 0.0% | 0.6% | -0.8% |
| 22 | Pictet Asset Management Holding SA | 682,909 | $26.6M | 0.0% | 0.6% | -1.9% |
| 23 | Vestal Point Capital, LP | 680,000 | $26.5M | 0.6% | 0.6% | -25.6% |
| 24 | NORTHERN TRUST CORP | 626,719 | $24.4M | 0.0% | 0.5% | +9.3% |
| 25 | Eversept Partners, LP | 602,922 | $23.5M | 1.2% | 0.5% | +152.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.